Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma
This study has been terminated.
( lack of accrual )
Study NCT00054834   Information provided by Immunomedics, Inc.
First Received: February 11, 2003   Last Updated: January 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-Hodgkins Lymphoma
Additional conditions recognized in this trial
Lymphoma
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
hLL2 (epratuzumab)
Sponsors listed in this trial
Immunomedics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services